Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG‐ACRIN E2805 trial-Reference-Cited by-同舟云学术

Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG‐ACRIN E2805 trial

Published:2021-08-18 Issue:17 Volume:10 Page:5917-5924
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Murphy Caitlin C.¹^ORCID,Fullington Hannah M.²,Gerber David E.³,Bowman Isaac Alex⁴^ORCID,Puligandla Maneka⁵,Dutcher Janice P.⁶,DiPaola Robert S.⁷,Haas Naomi B.⁸

Affiliation:

1. School of Public Health University of Texas Health Science Center at Houston (UTHealth) Houston TX USA

2. Department of Population and Data Sciences University of Texas Southwestern Medical Center Dallas TX USA

3. Department of Internal Medicine University of Texas Southwestern Medical Center Dallas TX USA

4. Banner MD Anderson Cancer Center Gilbert AZ USA

5. Department of Data Sciences Dana‐Farber Cancer Institute Boston MA USA

6. Cancer Research Foundation of New York Chappaqua NY USA

7. College of Medicine University of Kentucky Lexington KY USA

8. Division of Hematology‐Oncology Perelman School of Medicine University of Pennsylvania Philadelphia PA USA

Funder

National Center for Advancing Translational Sciences

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4140

Reference29 articles.

1. Extending the Quality and Safety Agenda From Parenteral to Oral Chemotherapy

2. Safe Handling of Oral Chemotherapeutic Agents in Clinical Practice: Recommendations From an International Pharmacy Panel

3. 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology

4. NCCN Task Force Report: Oral Chemotherapy

5. Polypharmacy and patterns of prescription medication use among cancer survivors